About Honeynaps Co.
Honeynaps Co. is a South Korean digital health company specializing in AI-driven sleep diagnostics, sleep disorder analytics, and next-generation sleep healthcare solutions. The company develops technologies that enhance access, efficiency, and clinical accuracy in sleep medicine through artificial intelligence and scalable healthcare platforms. Their flagship product, SOMNUM, is an AI-powered software that analyzes polysomnography (PSG) data to identify sleep stages and key events like apnea, hypopnea, and arousals, providing rapid sleep disorder diagnoses within minutes. SOMNUM has received U.S.0) expanding capabilities for automated analysis and classification of sleep-disordered breathing into Obstructive, Central, and Mixed Sleep Apnea.
For physicians, Honeynaps’ technology offers a significant advancement in sleep medicine by automating and accelerating the diagnostic process, which traditionally requires manual review taking several hours per case. SOMNUM’s deep learning-based AI analyzes large volumes of multi-channel/time series biosignals in real-time, aiming for high accuracy and transparency. The company is also developing next-generation AI technologies and digital biomarkers, including Hypoxic Burden (HB), Arousal Burden (AB), and Ventilatory Burden (VB), to enable more comprehensive evaluation of disease severity and associated health risks. Beyond sleep disorder diagnosis, Honeynaps plans to expand its AI applications to other critical areas such as cardiovascular disease, dementia, and Parkinson’s disease.
Focus Areas
Business Intelligence
| Technology | Deep learning-based AI, real-time analysis of multi-channel/time series biosignals, eXplainable Medical AI (XAI) technology, cloud-native platform |
What Physicians Need to Know
Honeynaps' solutions, particularly SOMNUMu2122, offer physicians a significant advantage by automating and accelerating the analysis of complex PSG data, reducing scoring time from several hours to mere minutes. The FDA clearance of SOMNUMu2122 (including V3.0 for sleep-disordered breathing classification) provides regulatory validation and assurance of the AI algorithm's clinical performance and reliability. The platform's ability to provide event-level classification and distinguish different apnea subtypes can lead to more accurate assessments and tailored treatment plans. Furthermore, their development of a wireless PSG system and contactless monitoring aims to improve patient comfort and enable broader use in both hospital and home settings. The company's focus on explainable AI (XAI) in SOMNUMu2122 enhances transparency and reliability, which can be crucial for physician trust and understanding of AI-driven diagnoses. Their expansion into CRO services also means they can support clinical trials for a wider range of therapeutic areas where sleep is a critical biomarker.
Honeynaps' SOMNUMu2122 Cloud offers a HIPAA-compliant, web-based platform for large-scale sleep data analysis, allowing users to upload EDF files from PSG devices for automated AI analysis and report generation without software installation. The company is also developing encoding/decoding software that supports international standard interfaces like HL7, DICOM, and ISO to ensure information compatibility with other medical fields. They are actively pursuing collaborations with leading US hospitals and sleep centers, and engaging in joint research and clinical partnerships with global pharmaceutical and medical device companies.
Videos
News, demos, and interviews about Honeynaps Co..
Videos load interactively. If none appear, search YouTube for Honeynaps Co. →
Frequently Asked Questions
Related Companies
Cymetica Biosciences, operating under the brand Biomiv, develops AI systems to create proprietary algorithms aimed at optimizing human health outcomes in real-time. Their work is rooted in research from human space flight, also known as ‘space biosciences,’ and biological language modeling. The company’s AI models construct proprietary vector embeddings to fine-tune AI, enabling the extraction […]
GPnotebook is a comprehensive clinical information and educational reference tool designed for healthcare professionals, particularly general practitioners. Established in 2001, it serves as a go-to resource for primary care professionals seeking quick answers to clinical questions during consultations. The platform features over 30,000 concise, evidence-based clinical reference articles, each focused on a specific primary care […]
LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]
Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They specialize in transforming fragmented clinical documentation into structured, contextualized data, which is essential for fueling AI models, accelerating workflows, and delivering measurable outcomes across various healthcare sectors including health systems, life sciences, […]
Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]
Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]
